Acalabrutinib
CAS NO.: 1420477-60-6
MF: C26H23N7O2
EINECS NO.: 814-272-0
MF: C26H23N7O2
EINECS NO.: 814-272-0
A229
Quantity
![]()

Acalabrutinib is a Bruton Tyrosine Kinase inhibitor that prevents the proliferation, trafficking, chemotaxis,
and adhesion of B cells.6 It is taken every 12 hours and can cause other effects such as atrial fibrillation,
other malignancies, cytopenia, hemorrhage, and infection
![]()
Acalabrutinib is a Bruton tyrosine kinase inhibitor used to treat mantle cell lymphoma,
chronic lymphocytic leukemia, and small lymphocytic lymphoma.



